Quantinno Capital Management LP Reduces Holdings in Avantor, Inc. (NYSE:AVTR)

Quantinno Capital Management LP lessened its position in Avantor, Inc. (NYSE:AVTR) by 21.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 109,836 shares of the company’s stock after selling 30,065 shares during the period. Quantinno Capital Management LP’s holdings in Avantor were worth $2,314,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in AVTR. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after purchasing an additional 625 shares during the period. Smartleaf Asset Management LLC grew its stake in Avantor by 106.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC raised its holdings in Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after acquiring an additional 1,067 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock worth $63,000 after purchasing an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC acquired a new position in shares of Avantor in the 4th quarter worth approximately $65,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Activity at Avantor

In other Avantor news, Director Gregory L. Summe purchased 25,000 shares of Avantor stock in a transaction that occurred on Wednesday, May 7th. The stock was acquired at an average price of $12.00 per share, with a total value of $300,000.00. Following the transaction, the director now owns 50,000 shares in the company, valued at $600,000. This trade represents a 100.00% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the sale, the chief accounting officer now directly owns 40,604 shares of the company’s stock, valued at $711,788.12. This represents a 10.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Morgan Stanley lowered Avantor from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, April 29th. Barclays decreased their target price on Avantor from $18.00 to $15.00 and set an “overweight” rating for the company in a research note on Monday, April 28th. Citigroup cut their price objective on Avantor from $22.00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Royal Bank of Canada decreased their price objective on shares of Avantor from $24.00 to $20.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. Finally, Raymond James reiterated an “outperform” rating and issued a $24.00 price objective (down previously from $26.00) on shares of Avantor in a research note on Monday, February 10th. Seven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $18.88.

Avantor Trading Up 0.9%

Shares of Avantor stock opened at $13.48 on Wednesday. Avantor, Inc. has a 1 year low of $11.82 and a 1 year high of $28.00. The company has a market capitalization of $9.19 billion, a price-to-earnings ratio of 12.96, a P/E/G ratio of 1.55 and a beta of 1.09. The business has a fifty day simple moving average of $14.67 and a two-hundred day simple moving average of $18.46. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.23. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a net margin of 10.49% and a return on equity of 12.17%. The firm’s quarterly revenue was down 5.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.22 earnings per share. Research analysts forecast that Avantor, Inc. will post 1.06 EPS for the current year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.